AstraZeneca plots China robot offensive to counter price cuts
WUXI, China/LONDON (Reuters) – With smart cancer diagnostics, one-stop-shop diabetes kits and AI systems to improve ambulance pick-ups for patients with chest pain, AstraZeneca (AZN.L) aims to move from simply…